Purification of pancreatic endocrine subsets reveals increased iron metabolism in beta cells
Year: 2020
Type: article
Abstract: OBJECTIVES: The main endocrine cell types in pancreatic islets are alpha, beta, and delta cells. Although these cell types have distinct roles in the regulation of glucose homeostasis, inadequate purification methods preclude the study of cell type-specific effects. We developed a reliable approach that enables simultaneous sorting of live alpha, beta, and delta cells from mouse islets for downstream analyses. METHODS: We developed an antibody panel against cell surface antigens to enable isolation of highly purified endocrine subsets from mouse islets based on the specific differential expression of CD71 on beta cells and CD24 on delta cells. We rigorously demonstrated the reliability and validity of our approach using bulk and single cell qPCR, immunocytochemistry, reporter mice, and transcriptomics. RESULTS: Pancreatic alpha, beta, and delta cells can be separated based on beta cell-specific CD71 surface expression and high expression of CD24 on delta cells. We applied our new sorting strategy to demonstrate that CD71, which is the transferrin receptor mediating the uptake of transferrin-bound iron, is upregulated in beta cells during early postnatal weeks. We found that beta cells express higher levels of several other genes implicated in iron metabolism and iron deprivation significantly impaired beta cell function. In human beta cells, CD71 is similarly required for iron uptake and CD71 surface expression is regulated in a glucose-dependent manner. CONCLUSIONS: This study provides a novel and efficient purification method for murine alpha, beta, and delta cells, identifies for the first time CD71 as a postnatal beta cell-specific marker, and demonstrates a central role of iron metabolism in beta cell function.
Source: Molecular Metabolism
Authors: C. Berthault, W. Staels, R. Scharfmann
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,070
Funders: Vanderbilt University, Leona M. and Harry B. Helmsley Charitable Trust, Juvenile Diabetes Research Foundation United States of America, European Federation of Pharmaceutical Industries and Associations, Fondation Francophone pour la Recherche sur le Diabète, European Commission, Agence Nationale de la Recherche, Fondation pour la Recherche Médicale, Diabetes Fonds, Vrije Universiteit Brussel, Fondation Bettencourt Schueller, Innovative Medicines Initiative, Stichting Diabetes Onderzoek Nederland, Horizon 2020 Framework Programme, Seventh Framework Programme, Staatssekretariat für Bildung, Forschung und Innovation
Awards: G175125242, G2552293092, G2665800701, G321357623, Amplifying human beta cell differentiation using small molecules, Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification, Identification of biomarkers of beta-cell stress and inflammation by exploring inter-organ communication inpreclinical models of obesity and type 2 diabetes, G7328074751
OpenAlex ID: W3047117816
